What is the expected growth forecast for the siRNA/miRNA Synthesis Service market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the siRNA/miRNA Synthesis Service market?

Key drivers include rising research activities and growing applications in therapeutics and diagnostics.

What are the major challenges facing the siRNA/miRNA Synthesis Service market?

Challenges include high production costs, regulatory hurdles, and off-target effects.

Which regions are leading the siRNA/miRNA Synthesis Service market?

North America and Europe are regional leaders, with Asia Pacific emerging as a growth hub.

Who are the top companies in the siRNA/miRNA Synthesis Service market?

Top companies include Thermo Fisher, Agilent, and Qiagen, offering a range of synthesis services.

What future opportunities exist in the siRNA/miRNA Synthesis Service market?

Future opportunities include personalized medicine, gene therapy, and emerging applications in agriculture.

How is technology impacting the siRNA/miRNA Synthesis Service market?

Advances in synthesis technologies, such as RNAi and CRISPR, are driving growth and innovation.

What is the current regulatory landscape for the siRNA/miRNA Synthesis Service market?

The regulatory landscape is evolving, with increasing focus on safety, efficacy, and manufacturing standards.

What is the future outlook for the siRNA/miRNA Synthesis Service market?

The future outlook is promising, with expected growth driven by increasing adoption and advancing technologies.

siRNA/miRNA Synthesis Service Industry Size, Share & Growth Forecast 2033

siRNA/miRNA Synthesis Service by Application (University, Research Institute, Others), by Types (Custom siRNA/miRNA Synthesis Service, Ordinary siRNA/miRNA Synthesis Service), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

siRNA/miRNA Synthesis Service Market Size | CAGR 15.2 Forecast 2033

siRNA/miRNA Synthesis Service Industry Size, Share & Growth Forecast 2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

siRNA/miRNA Synthesis Service Market Overview

The siRNA/miRNA Synthesis Service market refers to the industry that provides services for the synthesis of small interfering RNA (siRNA) and microRNA (miRNA), which are crucial for gene silencing and regulation. As the siRNA/miRNA Synthesis Service market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a significant expansion of the industry, driven by the increasing demand for RNA-based therapies. The industry expansion is further fueled by advancements in technology, government initiatives, and the growing need for personalized medicine, making it an attractive space for investors and researchers. The scope of this market encompasses services for the design, synthesis, and purification of siRNA and miRNA, catering to various applications such as research and development, diagnostics, and therapeutics.

Loading chart…

The current siRNA/miRNA Synthesis Service market size is expected to witness a significant growth forecast, with a compound annual growth rate (CAGR) of 15.6% from 2026 to 2033. The market is driven by macro drivers such as the increasing prevalence of genetic disorders, the rising demand for personalized medicine, and the growing adoption of RNA-based therapies. Key forces shaping the industry include technology shifts, such as the development of novel synthesis methods and the integration of artificial intelligence in siRNA/miRNA design, regulations, such as the stringent guidelines for RNA-based therapies, and competitive intensity, with major players competing for market share. The largest region in the siRNA/miRNA Synthesis Service market is North America, while the fastest-growing region is Asia-Pacific, driven by the increasing investments in biotechnology and the rising demand for RNA-based therapies in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Synbio-Tech; Horizon Discovery; Bioneer; Creative-Biolabs; Genecfps; Generay; Genscript; Sangon Biotech; Omics Bio; Beijing Tsingke Biotech; Creative Biogene Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The siRNA/miRNA Synthesis Service market is experiencing significant growth, driven by various factors. Understanding the market dynamics is crucial for stakeholders to make informed decisions.

Growth Drivers2 items

Increasing demand for siRNA/miRNA Synthesis Service in research and development activities, particularly in the fields of genetics and genomics, is driving the market growth. This demand is fueled by the rising focus on gene therapy and gene editing technologies.

Advancements in technology, such as the development of more efficient synthesis methods and the use of machine learning algorithms for sequence design, are also contributing to the growth of the siRNA/miRNA Synthesis Service market size.

Restraints2 items

High costs associated with siRNA/miRNA Synthesis Service, including the cost of raw materials, equipment, and labor, are limiting the adoption of these services, particularly among small and medium-sized research institutions.

Stringent regulations and guidelines governing the use of siRNA/miRNA in research and therapeutic applications are also hindering the growth of the siRNA/miRNA Synthesis Service market.

Opportunities2 items

The increasing focus on personalized medicine and targeted therapies is creating opportunities for the siRNA/miRNA Synthesis Service market to expand into new areas, such as cancer treatment and genetic disorders.

The growing demand for siRNA/miRNA-based therapeutics in emerging economies is also expected to drive the growth forecast of the siRNA/miRNA Synthesis Service market in the coming years.

Challenges2 items

Ensuring the quality and consistency of siRNA/miRNA synthesis is a significant challenge, particularly when dealing with complex sequences or large-scale production. This requires specialized expertise and equipment.

The siRNA/miRNA Synthesis Service market is also facing challenges related to intellectual property protection, as the development of new synthesis methods and sequences often involves significant investment in research and development.

Market Segmentation

Loading chart…

The Application segment of the siRNA/miRNA Synthesis Service market is a crucial aspect of the market taxonomy, as it defines the areas where these services are utilized. This segment includes subtypes such as cancer research, infectious disease research, and genetic disorder research. The application segment contributes significantly to the overall siRNA/miRNA Synthesis Service market size, as the demand for these services varies across different applications. Understanding the application segment is essential for businesses to tailor their services to meet the specific needs of researchers and organizations in each field, ultimately driving growth in the siRNA/miRNA Synthesis Service segmentation.

The Types segment of the siRNA/miRNA Synthesis Service market refers to the different types of synthesis services offered, including custom siRNA synthesis, custom miRNA synthesis, and RNA oligonucleotide synthesis. Each subtype has its own set of characteristics and requirements, and the demand for these services varies depending on the research goals and objectives. The types segment is critical in determining the overall market size, as it directly impacts the revenue generated by service providers. By analyzing the types segment, businesses can identify areas of opportunity and develop targeted strategies to enhance their siRNA/miRNA Synthesis Service offerings, ultimately contributing to the growth of the market.

siRNA/miRNA Synthesis Service Segmentation Breakdown7 items

Application

University

Research Institute

Others

Types

Custom siRNA/miRNA Synthesis Service

Ordinary siRNA/miRNA Synthesis Service

Regional Insights

Loading chart…

The siRNA/miRNA Synthesis Service market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of siRNA/miRNA synthesis services in countries such as China and Japan.

Key drivers for North America include investments in research and development, a mature ecosystem, and favorable policies. In Europe, drivers include a strong infrastructure, high adoption rates, and a growing focus on personalized medicine. Asia Pacific's growth is driven by increasing demographics, rising investment in biotechnology, and a growing ecosystem. Latin America's growth is driven by improving infrastructure, increasing adoption, and favorable policies. Middle East & Africa's growth is driven by increasing investment, a growing ecosystem, and rising demand for siRNA/miRNA synthesis services.

The regional forecast indicates that Asia Pacific will experience the highest growth rate, driven by the increasing demand for siRNA/miRNA synthesis services in the pharmaceutical and biotechnology industries. The siRNA/miRNA Synthesis Service market growth in Latin America and Middle East & Africa is expected to be moderate, driven by improving infrastructure and increasing adoption rates.

Competitive Landscape

The siRNA/miRNA Synthesis Service competitive landscape is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market is characterized by high competition, with companies focusing on differentiation through technology, service model, and channel strength. Understanding the siRNA/miRNA Synthesis Service competitive landscape is crucial for companies to develop effective strategies and stay ahead in the market.

Companies in the siRNA/miRNA Synthesis Service market employ various strategies to differentiate themselves and gain a competitive edge. Common strategies include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To overcome these challenges, companies must focus on innovative technologies, premium services, and strong channel partnerships. The following companies have adopted different strategic focuses:

Synbio-Tech: regional expansion

Horizon Discovery: innovation pipeline

Bioneer: OEM tie-ups

Creative-Biolabs: premium pricing

Genecfps: local manufacturing

Genscript: vertical integration

Key siRNA/miRNA Synthesis Service Companies11 items

Synbio-Tech

Horizon Discovery

Bioneer

Creative-Biolabs

Genecfps

Generay

Genscript

Sangon Biotech

Omics Bio

Beijing Tsingke Biotech

Creative Biogene Biotechnology

Market Ecosystem

The siRNA/miRNA Synthesis Service ecosystem encompasses a complex network of participants, from upstream technology providers to downstream end users. This ecosystem can be broadly segmented into three main stages: upstream, where raw materials and technologies are sourced; midstream, where integrators and service providers create value-added services; and downstream, where channels and end users ultimately capture value. The siRNA/miRNA Synthesis Service ecosystem is characterized by the creation and capture of value through the synthesis and application of siRNA and miRNA molecules.

Raw material suppliers — provide nucleotides and reagents

Technology providers — develop synthesis platforms and methods

Service providers — offer custom synthesis and manufacturing services

System integrators — integrate synthesis services with downstream applications

Distributors — supply synthesized siRNA/miRNA molecules to end users

End users — research institutions and pharmaceutical companies

Regulators — establish standards and guidelines for siRNA/miRNA synthesis and application

In the siRNA/miRNA Synthesis Service ecosystem, control points are primarily held by technology providers and service providers, who influence adoption through their expertise and capabilities. Dependency risks arise from input constraints, such as the availability of high-quality nucleotides, and regulatory approvals, which can impact the synthesis and application of siRNA and miRNA molecules. Furthermore, switching costs and partnerships between service providers and end users can also affect the ecosystem. As the ecosystem differs by region, with varying regulatory requirements and market demands, a thorough value chain analysis is necessary to understand the complex interactions and relationships within the siRNA/miRNA Synthesis Service ecosystem.

Recent Industry Insights

The siRNA/miRNA Synthesis Service industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in technology and increasing demand for innovative therapeutics. Recent partnerships between key players have focused on enhancing service offerings and expanding global reach. Notable mergers and acquisitions have also occurred, leading to consolidation and strengthened market positions. Furthermore, several companies have launched new products and technologies, including improved synthesis platforms and expanded libraries of siRNA and miRNA sequences.

In addition to these developments, regulatory changes have supported the growth of the siRNA/miRNA synthesis service market, with updated guidelines and approvals facilitating the development of siRNA and miRNA-based therapies. A shift in consumer and enterprise trends towards personalized medicine has also driven interest in customized siRNA and miRNA synthesis services. Funding rounds and expansions have provided companies with the necessary resources to invest in research and development, further fueling innovation in the siRNA/miRNA synthesis service industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the siRNA/miRNA Synthesis Service market outlook. The market attractiveness is high, driven by increasing demand for innovative therapies and growing research in the field of RNA interference. The competitive intensity is moderate, with a few key players dominating the market. The long-term outlook is promising, with expected growth in the pharmaceutical and biotechnology sectors.

The innovation landscape is rapidly evolving, with advancements in gene editing and RNA synthesis technologies. However, the demand-supply balance is a concern, with potential bottlenecks in production capacity. Key risk factors include regulatory challenges and intellectual property disputes. Overall, the siRNA/miRNA Synthesis Service market offers opportunities for growth and investment, but careful consideration of these factors is necessary for informed decision-making.

11 items

1. Executive Summary

2. siRNA/miRNA Synthesis Service Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global siRNA/miRNA Synthesis Service Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global siRNA/miRNA Synthesis Service Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. University

6.1.2. Research Institute

6.1.3. Others

6.2. Global siRNA/miRNA Synthesis Service Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Custom siRNA/miRNA Synthesis Service

6.2.2. Ordinary siRNA/miRNA Synthesis Service

6.3. Global siRNA/miRNA Synthesis Service Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global siRNA/miRNA Synthesis Service Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global siRNA/miRNA Synthesis Service Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global siRNA/miRNA Synthesis Service Market Competition by Key Manufacturers

8.1. Global siRNA/miRNA Synthesis Service Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global siRNA/miRNA Synthesis Service: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Synbio-Tech

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Horizon Discovery

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Bioneer

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Creative-Biolabs

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Genecfps

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Generay

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Genscript

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Sangon Biotech

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Omics Bio

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Beijing Tsingke Biotech

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Creative Biogene Biotechnology

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global siRNA/miRNA Synthesis Service Market

Figure 4: Global siRNA/miRNA Synthesis Service Market: Drivers

Figure 5: Global siRNA/miRNA Synthesis Service Market: Challenges

Figure 6: Global siRNA/miRNA Synthesis Service Market: Trends

Figure 7: Global siRNA/miRNA Synthesis Service Market: Opportunity

Figure 8: Global siRNA/miRNA Synthesis Service Market: Restraint

Figure 9: Global siRNA/miRNA Synthesis Service Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global siRNA/miRNA Synthesis Service Market Value (USD Million) By Region

Figure 15: Global siRNA/miRNA Synthesis Service Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global siRNA/miRNA Synthesis Service Market Value (USD Million) By Region

Figure 23: Global siRNA/miRNA Synthesis Service Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global siRNA/miRNA Synthesis Service Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global siRNA/miRNA Synthesis Service Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global siRNA/miRNA Synthesis Service Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global siRNA/miRNA Synthesis Service Market Value (USD Million) By Region

Table 10: Global siRNA/miRNA Synthesis Service Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global siRNA/miRNA Synthesis Service Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global siRNA/miRNA Synthesis Service Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global siRNA/miRNA Synthesis Service Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Synbio-Tech Basic Information And Sales Area

Table 31: Synbio-Tech. Products Portfolio

Table 32: Horizon Discovery Basic Information And Sales Area

Table 33: Horizon Discovery. Products Portfolio

Table 34: Bioneer Basic Information And Sales Area

Table 35: Bioneer. Products Portfolio

Table 36: Creative-Biolabs Basic Information And Sales Area

Table 37: Creative-Biolabs. Products Portfolio

Table 38: Genecfps Basic Information And Sales Area

Table 39: Genecfps. Products Portfolio

Table 40: Generay Basic Information And Sales Area

Table 41: Generay. Products Portfolio

Table 42: Genscript Basic Information And Sales Area

Table 43: Genscript. Products Portfolio

Table 44: Sangon Biotech Basic Information And Sales Area

Table 45: Sangon Biotech. Products Portfolio

Table 46: Omics Bio Basic Information And Sales Area

Table 47: Omics Bio. Products Portfolio

Table 48: Beijing Tsingke Biotech Basic Information And Sales Area

Table 49: Beijing Tsingke Biotech. Products Portfolio

Table 50: Creative Biogene Biotechnology Basic Information And Sales Area

Table 51: Creative Biogene Biotechnology. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global siRNA/miRNA Synthesis Service Market Value (USD Million) By Region

Table 57: Global siRNA/miRNA Synthesis Service Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

siRNA/miRNA Synthesis Service Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Synbio-Tech; Horizon Discovery; Bioneer; Creative-Biolabs; Genecfps; Generay; Genscript; Sangon Biotech; Omics Bio; Beijing Tsingke Biotech; Creative Biogene Biotechnology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options